Malvern Panalytical acquires Dimer Instruments to accelerate innovation in biopharmaceutical analysis

Malvern Panalytical, a market-leader in material characterization technologies, today (October 9) announces the acquisition of Dimer Instruments – a developer of cutting-edge technologies for biopharmaceutical analysis. Headquartered in Santa Barbara, CA, Dimer Instruments was founded by industry veterans Dr. Stephen Minne and Dr. Michael Larkin, who bring deep expertise in biophysical characterization and analytical instrumentation. Malvern [...]

Entering the Core Laboratory Market Development and Validation of a Mass Spectrometry Solution for Core Laboratories Begins at an Australian Hospital

Shimadzu Corporation has started the development and validation of a mass spectrometry solution for core laboratories at St. Vincent’s Hospital in Melbourne, Victoria, Australia. Shimadzu’s LC-MS-based automation solution has been integrated with Abbott Laboratories’ AlinIQ AMS laboratory informatics solution to streamline and automate clinical testing workflows in core laboratories. The solution is being developed and [...]

Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development

Investment strengthens Bio-Techne's global GMP manufacturing infrastructure for cell therapy applications New Bristol facility expands GMP small molecule production capacity and complements recent investments in North America Combined capabilities across Bristol, St. Paul and Minneapolis support customers from discovery through commercial manufacturing MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents [...]

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

BOSTON -- SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous recombination deficiency (HRD) in prostate cancer patients. The [...]

Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula’s Lab-in-the-Loop

The Endeavor® adds the fastest high-content cellular data generation to Ginkgo's around-the-clock research  PORTLAND, Ore. and BOSTON -- Araceli Biosciences and Ginkgo Bioworks (NYSE: DNA) today announced the integration of Araceli's Endeavor® high-content imaging instrument into Nebula, Ginkgo's autonomous lab in Boston. The Endeavor, the world's fastest high-content imaging system, brings cellular imaging with real-time analysis [...]

Illumina releases SpliceAI2 to help advance rare disease research

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina's genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of [...]

BPS Bioscience Licenses Monod Bio’s AI-Designed Proteins to Develop Novel Research Products and Services

Agreement enables BPS Bioscience to integrate Monod’s LuxSitTM Pro luciferase and NovoBodyTM binders into future discovery products and services SEATTLE and SAN DIEGO — Monod Bio and BPS Bioscience today announced a non-exclusive licensing agreement covering Monod Bio’s LuxSit Pro de novo luciferase and NovoBody binding proteins. BPS plans to integrate the technologies into the development [...]

Simulations Plus Announces Funded Partnership with Global Pharmaceutical Company to Advance AI-Enabled QSP Model Development with Turin

Collaboration will apply Turin to explore mechanistic QSP model structures at scale and bring insights to development decisions where traditional modeling timelines have limited their use RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today [...]

Phenomenex Introduces Strata-Mag RP to Enable Automated LC-MS/MS Sample Preparation at Scale

Magnetic bead technology supports scalable sample preparation for high-throughput LC-MS/MS applications in clinical research workflows. TORRANCE, Calif. -- Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies for the separation sciences, today announced the launch of Strata-Mag RP, a magnetic bead-based extraction technology designed to help clinical research [...]

Hudson Lab Automation opens new headquarters, ushering in next chapter of innovation

New facility expands Hudson’s space for product development and introduces a new customer demo lab CEO Werner Maas and other team members cut the ribbon during the grand opening ceremony Hudson Lab Automation, a global laboratory automation solutions provider, today announced the opening of its new headquarters in New Providence, New Jersey. The expanded facility [...]

Access IBO on Knowledge Center